Source: GlobeNewswire

Press Release: Labtician : DIAGNOS Announces its Exclusive Strategic Partnership Agreement with Labtician Ophthalmics, a Leader in Canadian and International Eyecare Markets to Address Growing Needs in the Monitoring of Diabetic and Hypertensive Patients

BROSSARD, Quebec, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces its exclusive strategic partnership agreement with Labtician Ophthalmics ("Labtician"), a Toronto-based company with customers across Canada who will introduce and commercialize DIAGNOS AI platform to monitor ocular health and improve patient care in diabetic patients. An initial agreement with Labtician was announced on June 3rd, 2020.

Read full article »
Est. Annual Revenue
Est. Employees
CEO Avatar


Update CEO

CEO Approval Rating

- -/100

Labtician is headquartered in Oakville, Ontario. Labtician has a revenue of $7.2M, and 59 employees.